buyModerate cluster of 4
Gv 2021 Gp, L.l.c. bought $5.0M of PRME
owner at Prime Medicine, Inc.. 1,500,000 shares at an average of $3.30, traded Aug 1, 2025, filed Aug 5, 2025.
Conviction score
57Value
$5.0M
1,500,000 shares
Holdings after
3,262,440
+85% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$5.0M at market
- +10Relative to holdingsHoldings up 85%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-021025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 1, 2025 | POpen-market purchase Common Stockindirect: By GV 2021, L.P. | +1,500,000 | $3.30 | $5.0M | 3,262,440 | Aug 5, 2025 |
Related signals
Other insiders at Prime Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | Prime Medicine, Inc. | ARCH Venture Partners X, LLC owner | $10.0M 3,030,300 shares | +95% | |
| 57Moderate | Prime Medicine, Inc. | ARCH Venture Partners XII, LLC owner | $10.0M 3,030,300 shares | +95% | |
| 65Notable | Prime Medicine, Inc. | Robert Nelsen director, owner | $10.0M 3,030,300 shares | +95% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $53k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $45k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $31k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $34k 21,000 shares | +0% | |
| 38Weak | Prime Medicine, Inc. | Richard Brudnick Chief Business Officer | $24k 20,000 shares | - | |
| 48Moderate | Prime Medicine, Inc. | Ann L. Lee Chief Technical Officer | $113k 100,000 shares | - | |
| 59Moderate | Prime Medicine, Inc. | Allan Reine Chief Executive Officer | $147k 125,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.